Tivantinib
(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
Molecular Identity
Tivantinib
(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
PubChem CID: 11494412
LSM-1131 is a member of indoles.
2D Structure
Properties
C23H19N3O2
Molecular Formula
369.40
Molecular Weight
g/mol
369.1477
Exact Mass
Da
2.9
XLogP
Drug-like (Lipinski: < 5)
66.9
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
2
H-Bond Acceptors
666
Complexity
SMILES
Canonical SMILES
SMILES: C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65Isomeric SMILES
SMILES: C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65Synonyms(20)
Tivantinib905854-02-6ARQ-197(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dioneARQ 197ARQ197PJ4H73IL17DTXSID60920316(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dionetivantinibumRefChem:898517c-Met Inhibitor ARQ 197DTXCID301349230(3R,4R)-3-(1-azatricyclo(6.3.1.0^(4,12))dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dioneTivantinib (ARQ 197)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tivantinib
Loading drug network...